Column GROUP L P, Director, 10% Owner, Ten Percent Owner Other at NGM BIOPHARMACEUTICALS INC (NGM), bought 128,178 shares at $17.67 ($2.3M) on 2020-09-02, disclosed to the SEC on 2020-09-03.
Open-market purchase of $2.3M NGM by Director, 10% Owner, Ten Percent Owner Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.64 | 36,494 | $644K | 28.5% |
| 2 | $17.64 | 36,494 | $644K | 28.5% |
| 3 | $17.67 | 27,595 | $488K | 21.5% |
| 4 | $17.67 | 27,595 | $488K | 21.5% |
| Total | $17.65 avg | 128,178 | $2.3M | 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |